Home › Hemophilia B › Georgia › Atlanta
Hemophilia B clinical trials in Atlanta, GA
4 studies for Hemophilia B are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
RecruitingPhase 3
- Arthur M. Blank Hospital - Children's Healthcare of Atlanta, Atlanta
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
RecruitingPhase 3
- Children's Healthcare of Atlanta, Atlanta
- Emory University Hospital, Atlanta
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
- Emory/Children's Health Care of Atlanta, Atlanta
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
RecruitingPhase 4
- Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division, Atlanta
Hemophilia B trials in other cities
- Philadelphia, PA5 studies
- Sacramento, CA4 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Ann Arbor, MI4 studies
- Indianapolis, IN3 studies
- Seattle, WA3 studies
- San Francisco, CA3 studies
- Greenville, NC3 studies
- Nashville, TN3 studies
- Gainesville, FL3 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Multiple Myeloma42 studies
- Breast Cancer41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia31 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Metastatic Cancer28 studies
- Major Depressive Disorder25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.